Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Stavudine MeSH Descriptor Data 2025


MeSH Heading
Stavudine
Tree Number(s)
D03.383.742.680.705.875
D13.570.230.500.850
D13.570.230.855.875
D13.570.685.705.875
Unique ID
D018119
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D018119
Scope Note
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Entry Term(s)
2',3'-Didehydro-2',3'-dideoxythmidine
2',3'-Didehydro-3'-deoxythymidine
BMY-27857
D4T
Stavudine, Monosodium Salt
Zerit
Pharm Action
Antimetabolites
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
BO9LE4QFZF
134624-73-0
0
Related Numbers
134624-73-0
3056-17-5
CAS Type 1 Name
Thymidine, 2',3'-didehydro-3'-deoxy-
Previous Indexing
Dideoxynucleosides (1989-1993)
Thymidine/analogs & derivatives (1987-1988)
Public MeSH Note
1994; STAVUDINE was indexed under DIDEOXYNUCLEOSIDES 1988-93 and under THYMIDINE/*ANALOGS & DERIVATIVES 1987-88
History Note
1994; use STAVUDINE 1987-93
Date Established
1994/01/01
Date of Entry
1993/06/04
Revision Date
2017/05/24
Stavudine Preferred
Stavudine, Monosodium Salt Narrower
BMY-27857 Narrower
Zerit Narrower
page delivered in 0.146s